{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:14:08Z","timestamp":1790745248430,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bja.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T20:13:54Z","timestamp":1554495234000},"page":"e144-e150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Assessing cross-reactivity to neuromuscular blocking agents by skin and basophil activation tests in patients with neuromuscular blocking agent anaphylaxis"],"prefix":"10.1016","volume":"123","author":[{"given":"Jamma","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver G.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Capon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict A.","family":"Krupowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suran L.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2019.03.001_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0310057X1704500504","article-title":"Australian and New Zealand anaesthetic allergy group perioperative anaphylaxis investigation Guidelines","volume":"45","author":"Scolaro","year":"2017","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2019.03.001_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/306262a0","article-title":"Substituted ammonium ions as allergenic determinants in drug allergy","volume":"306","author":"Baldo","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bja.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2222.2008.03171.x","article-title":"On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective","volume":"39","author":"Baldo","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.bja.2019.03.001_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/bja\/87.5.755","article-title":"Structure, conformation, and action of neuromuscular blocking drugs","volume":"87","author":"Lee","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2174\/138161208786369704","article-title":"Hypersensitivity reactions to neuromuscular blocking agents","volume":"14","author":"Mertes","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bja.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/bja\/aes506","article-title":"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011","volume":"110","author":"Sadleir","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.iac.2009.04.008","article-title":"Provocation tests in drug hypersensitivity","volume":"29","author":"Aberer","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.bja.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jaip.2018.02.008","article-title":"Hypersensitivity to neuromuscular blocking agents: can skin tests give the green light for re-exposure?","volume":"6","author":"Sabato","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.bja.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaci.2013.06.038","article-title":"Basophil activation testing","volume":"132","author":"MacGlashan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bja.2019.03.001_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/aas.13077","article-title":"Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines","volume":"62","author":"Rose","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2019.03.001_bib11","unstructured":"Li J, Best O, Green S, Rose M, Fulton R, Fernando S. Integrating basophil activation tests into the routine evaluation of perioperative anaphylaxis to neuromuscular blocking agents at a dedicated Anaesthetics Allergy Clinic in Sydney, Australia. Br J Anaesth [update BJA-2018-01876-HH846]."},{"key":"10.1016\/j.bja.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1398-9995.2006.01094.x","article-title":"Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide","volume":"61","author":"Ebo","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0091-6749(87)80152-5","article-title":"Role of the quaternary ammonium ion determinants in allergy to muscle relaxants","volume":"79","author":"Didier","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bja.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02802308","article-title":"Allergy to muscle relaxants","volume":"9","author":"Birnbaum","year":"1991","journal-title":"Clin Rev Allergy"},{"key":"10.1016\/j.bja.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1398-9995.2011.02753.x","article-title":"Negative predictive value of skin tests to neuromuscular blocking agents","volume":"67","author":"Ramirez","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cea.12632","article-title":"General anesthesia-induced anaphylaxis: impact of allergy testing on subsequent anesthesia","volume":"46","author":"Trautmann","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.bja.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bja.2018.03.004","article-title":"Safety of subsequent general anaesthesia in patients allergic to neuromuscular blocking agents: value of allergy skin testing","volume":"120","author":"Chiriac","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/0310057X0503300620","article-title":"Anaphylaxis to cisatracurium following negative skin testing","volume":"33","author":"Fraser","year":"2005","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bja.2019.03.001_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bja.2019.03.001_bib22","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navines-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bja.2019.03.001_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0310057X1604400306","article-title":"Early skin and challenge testing after rocuronium anaphylaxis","volume":"44","author":"Schulberg","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/cea.12344","article-title":"Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need","volume":"44","author":"Leysen","year":"2014","journal-title":"Clin Exp Allergy"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091219301618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091219301618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:55:09Z","timestamp":1757789709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091219301618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0007091219301618"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2019.03.001","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing cross-reactivity to neuromuscular blocking agents by skin and basophil activation tests in patients with neuromuscular blocking agent anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}